Evidence map›Paper›PMID 28326798›Full record

ArticleAnnals of the American Thoracic Society2017

Indwelling Pleural Catheters for Patients with Hematologic Malignancies. A 14-Year, Single-Center Experience.

Saadia A Faiz, Priyanka Pathania, Juhee Song, Liang Li, Diwakar D Balachandran, David E Ost, Rodolfo C Morice, Vickie R Shannon, Lara Bashoura, Georgie A Eapen and 1 more

Abstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Malignant pleural disease.Breathe (Sheffield, England) · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Saadia A Faiz1 Department of Pulmonary Medicine, and.ORCID http://orcid.org/0000-0001-7284-3945
Priyanka Pathania2 Division of Pulmonary, Critical Care Medicine, and Sleep Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
Juhee Song3 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Liang Li3 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Diwakar D Balachandran1 Department of Pulmonary Medicine, and.ORCID http://orcid.org/0000-0002-7427-9388
David E Ost1 Department of Pulmonary Medicine, and.ORCID http://orcid.org/0000-0001-6351-5552
Rodolfo C Morice1 Department of Pulmonary Medicine, and.
Vickie R Shannon1 Department of Pulmonary Medicine, and.ORCID http://orcid.org/0000-0002-5938-4841
Lara Bashoura1 Department of Pulmonary Medicine, and.
Georgie A Eapen1 Department of Pulmonary Medicine, and.ORCID http://orcid.org/0000-0001-6408-6964
Carlos A Jimenez1 Department of Pulmonary Medicine, and.
Pulmonary Associates · USThe University of Texas MD Anderson Cancer Center · USThe University of Texas Health Science Center at Houston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

rationalePlacement of an indwelling pleural catheter is an established modality for symptom relief and pleurodesis in the treatment of malignant pleural effusion. Concerns remain regarding possible infectious complications, risk of hemorrhage, and the rate of pleurodesis with the use of pleural catheters in the treatment of hematologic malignancies.

objectivesThe goals of our study were: (1) to evaluate the safety and cumulative incidence of pleurodesis with indwelling pleural catheters for patients with hematologic malignancies, and (2) to evaluate overall survival of this cohort of patients with pleural effusions.

methodsWe performed a retrospective review of 172 patients with a hematologic malignancy who underwent placement of an indwelling pleural catheter between September 1997 and August 2011 at the University of Texas MD Anderson Cancer Center in Houston, Texas. A competing risk model analysis was used for complications and pleurodesis. Analysis was based on each patient's first intrapleural catheter.

resultsThere were 172 patients with lymphoma (58%), acute (16%) or chronic leukemia (16%), or multiple myeloma (10%). The effusions were characterized as malignant (85.5%), infectious (4.1%), volume overload (4.7%), or therapy-related (4.7%). Chylothorax was found in 20.1%. Pleural biopsies were obtained from 13 patients. The cumulative incidence of all complications was 13.6%, and the cumulative incidence of all significant catheter-related complications was 9.5%. The incidence of empyema was 2.9%, and major bleeding (requiring transfusion or intervention) was 1.7%. Thirty-day procedure-associated mortality was 0.6%. The cumulative incidence of pleurodesis at 180 days was 50%, with a median time to pleurodesis of 81 days for the entire cohort.

conclusionsIndwelling pleural catheters appear to be safe for patients with hematologic malignancies. Complications and the cumulative incidence of pleurodesis are comparable to those reported for patients with solid organ malignancies.

Indexed as

AdultAgedAged, 80 and overCatheters, IndwellingDrainageFemaleHematologic NeoplasmsHumansMaleMiddle AgedPleuraPleural Effusion, MalignantPleurodesisPostoperative ComplicationsRetrospective StudiesSurvival Analysisempyemahematologic malignanciesindwelling pleural cathetermalignant pleural effusionpleurodesis

Identifiers

PMID28326798
PMCPMC5566308
OpenAlexW2602283635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.